Medtronic Inc (MDT) 77.61 $MDT
North American Orthobiologics (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015-2019
M2 - Fri Apr 24, 9:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rkbq8c/north_american) has announced the addition of the "North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019" report to their offering. The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market. The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market. In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market. The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.). For more information visit http://www.researchandmarkets.com/research/rk...h_american
MDT: 77.61 (-0.89), GMED: 24.79 (+0.15), EXAC: 24.40 (+0.15), SYK: 96.90 (-0.28)
Pfizer's Once And Future Deals
Chris DeMuth Jr. - at Seeking Alpha - Thu Apr 23, 2:39PM CDT
SHAK: 68.53 (+5.80), GS: 197.99 (-1.32), MDT: 77.61 (-0.89), JPM: 62.60 (-0.20), SHPG: 255.11 (-0.26), COV: 106.71 (-1.36), PFE: 35.27 (-0.09), AZN: 71.79 (-1.34), BAC: 15.64 (-0.05), ABBV: 66.07 (+1.82), HSP: 87.61 (-0.05), MS: 37.36 (-0.02)
Global Weight Loss and Weight Management Market 2015-2019
M2 - Thu Apr 23, 8:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dhhrwt/weight_loss_and) has announced the addition of the "Weight Loss and Weight Management Market by Equipment, Surgical Equipment , Diet , Weight Loss Services - Forecast to 2019" report to their offering. The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9% from 2014 to 2019 Factors such as rising obesity rates, increasing risks of lifestyle diseases, increasing number of bariatric surgeries, increase in disposable incomes, and technological advancements are driving the growth of the weight loss and weight management market. Furthermore, strong government support and funding is another major factor promoting growth of this market. For instance, the U.K. government started theChange4Life initiative in 2009, a multipronged approach that encourages behavioral changes in people and includes marketing strategies such as advertising campaigns, websites, resources, and partnership opportunities to encourage people to eat well and live longer. Moreover, the U.K. government announced the launch of Call to Action on Obesity program. This program aims to set a weight reduction trend among children and adults by 2020. The program has also issued a calorie reduction challenge to the food and beverage industry to reduce daily calorie intake. Such support is likely to provide impetus for growth of this market. The relatively untapped Asian region provides an array of growth opportunities for the weight loss and weight management market. Large population base, rapid urbanization, increasing disposable incomes, rising prevalence of obesity, and growing awareness and health consciousness among citizens are the factors responsible for the growth of this market. To leverage these market opportunities and to reduce the manufacturing and distribution costs, various market players are building manufacturing facilities and strengthening their sales force in these developing economies. However, high cost of low-calorie diets and deceptive marketing strategies adopted by industry players are hindering the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.4 Weight Loss Management Market, By Diet 5 Market Overview 6 Industry Insights 7 Weight Loss & Weight Management Market, By Diet 8 Weight Loss & Weight Management Market, By Equipment 9 Weight Loss & Weight Management Market, By Service 10 Weight Loss & Weight Management Market, By Region 11 Competitive Landscape 12 Company Profiles - Amer Sports - Apollo Endosurgery, Inc. - Atkins Nutritionals, Inc. - Brunswick Corporation - Covidien PLC (Wholly-Owned Subsidiary of Medtronic PLC) - Cybex International, Inc. (A Wholly Owned Subsidiary of Um Holdings) - Ediets.Com, Inc. (A Wholly Owned Subsidiary of as Seen on TV, Inc.) - Ethicon (Subsidiary of Johnson & Johnson) - Herbalife Ltd. - Jenny Craig, Inc. (Subsidiary of North Castle Partners) - Johnson Health Technology Co., Ltd. - Kellogg Company - Nutrisystem, Inc. - Technogym SPA - Weight Watchers International, Inc. For more information visit http://www.researchandmarkets.com/research/dh...t_loss_and
JNJ: 101.08 (+0.62), HLF: 41.10 (-3.75), MDT: 77.61 (-0.89), BC: 55.27 (+0.78), WTW: 8.25 (+0.15), K: 63.73 (-0.12)
Global Electrophysiology Market Report 2014-2020
M2 - Thu Apr 23, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4wjt34/electrophysiology) has announced the addition of the "Electrophysiology Global Market Analysis - Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Electrophysiology. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Electrophysiology Market by Diagnostic Devices 5.1 X-ray Systems 5.2 Diagnostic Catheters 5.3 EMG 5.4 ECG 5.5 EEG 6 Electrophysiology Market by Therapeutic Devices 6.1 Cardiac Pacemakers 6.2 CRT 6.3 ICDs 6.4 Ablation Catheters 7 Geographical Segmentation 8 Vendor Landscaping 9 Company Profiles - Abbott Laboratories - Biotronik - Boston Scientific Corp. - C.R. Bard Inc. - Medtronic, Inc. - Siemens AG - St. Jude Medical Inc. For more information visit http://www.researchandmarkets.com/research/4w...physiology
BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), BCR: 175.38 (-0.87), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.21% Rise
Comtex SmarTrend(R) - Wed Apr 22, 4:22PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 77.61 (-0.89)
After Yesterday's Rally of 1.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:21PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 77.61 (-0.89)
Inspire Therapy Approved for Sleep Apnea Patients at Military and VA Hospitals
PR Newswire - Wed Apr 22, 10:46AM CDT
Inspire Medical Systems, Inc., announced today that Inspire® Upper Airway Stimulation (UAS) therapy has been approved for inclusion in the Government Services Administration (GSA) Federal Supply Schedule (FSS). The agreement enables access to Inspire therapy to patients cared for at Veteran Administration hospitals, military treatment facilities, and Indian Health Services hospitals. Inspire therapy is an FDA approved implantable device for the treatment of Obstructive Sleep Apnea (OSA), a common condition affecting 18 million Americans.
MDT: 77.61 (-0.89)
North American Nerve Repair & Regeneration Market by Type, by Procedure - Forecast to 2019
M2 - Wed Apr 22, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hs9468/north_american) has announced the addition of the "North American Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) -Forecast to 2019" report to their offering. The North American nerve repair and regeneration market was valued at $1,671.4 million in 2014. It is projected to reach $2,873.0 million by 2019, at a CAGR of 11.4% during the forecast period. The market, by type, is segmented into nerve repair by neurostimulation (held largest share in 2014) and nerve repair by biomaterials. In North America, the U.S. is a key region the for nerve repair and regeneration market. Nerve repair and regeneration deals with healing damaged nerves and restoring any functioning of body parts lost due to nerve damage. This is one of the more challenging of neurological procedures. The growth of nerve repair and regeneration market has been rapid in all countries, mainly due to the constantly rising surgeries pertaining to nerves and the high incidence of chronic neurological disorders like epilepsy, Parkinson's, and Alzheimer's diseases. The increase in neurological surgeries drives the need for products such as nerve conduits, wraps, protectors, and connectors; thus, it is a driver of market growth. The North American nerve repair and regeneration market constitutes 32.8% of the global nerve repair and regeneration. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Product 6 Nerve Repair and Regeneration Market, By Country 7 Nerve Repair and Regeneration Market: Competitive Landscape 8 Nerve Repair and Regeneration Market: Company Profiles - Axogen, Inc. - Integra Lifesciences Corporation - Medtronic, Plc. - Polyganics - St. Jude Medical - Stryker For more information visit http://www.researchandmarkets.com/research/hs...h_american
MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Medtronic DBS systems cleared for full-body MRI in Europe
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 9:38AM CDT
MDT: 77.61 (-0.89)
Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) - Forecast to 2019
M2 - Wed Apr 22, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2c5p7/asian_internal) has announced the addition of the "Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019" report to their offering. The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019 Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market. In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Asia-Pacific Internal Neuromodulation/Neurostimulation Market: Macro Indicators, By Geography, 2014 ($ Bn) 4 Executive Summary 5 Market Overview 6 Internal Neurostimulation/Neuromodulation Market, By Modality 7 Internal Neurostimulation/Neuromodulation Market, By Application 8 Internal Neurostimulation/Neuromodulation Market, By Geography 9 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape 10 Internal Neurostimulation/ Neuromodulation Market, By Company - Boston Scientific Corporation (U.S.) - Cerbomed Gmbh (Germany) - Cyberonics, Inc. (U.S.) - Depuy Synthes Companies (U.S.) - Enteromedics, Inc. (U.S.) - Medtronic, Inc. (U.S.) - St. Jude Medical (U.S.) - Synapse Biomedical, Inc. (U.S.) - Uroplasty, Inc. (U.S.) For more information visit http://www.researchandmarkets.com/research/c2...n_internal
BSX: 18.34 (-0.08), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54), UPI: 1.22 (-0.03), CYBX: 62.89 (-0.30)
Health Care Equipment and Supplies Equities Technical Data - Medtronic, ResMed, Unilife, Edwards Lifesciences, and InspireMD
PR Newswire - Wed Apr 22, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
UNIS: 3.56 (-0.18), MDT: 77.61 (-0.89), RMD: 65.70 (-7.68), EW: 138.33 (-3.59), NSPR: 0.26 (-0.02)
3 Things to Know About Apple and IBM's Most Recent Cloud Computing Innovation
Andrew Tonner, The Motley Fool - Motley Fool - Tue Apr 21, 1:03PM CDT
IBM's and Apple's CEOs. Image source: IBM Beyond plenty of publicity, just what have Apple and IBM gained from the much-ballyhooed partnership they announced last July? Well, since then, Apple and IBM have introduced 23 enterprise-focused...
JNJ: 101.08 (+0.62), MDT: 77.61 (-0.89), IBM: 169.78 (-0.46), AAPL: 130.28 (+0.61)
Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System
M2 - Tue Apr 21, 11:26AM CDT
Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery (LSA).
MDT: 77.61 (-0.89)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 77.61 (-0.89), SYK: 96.90 (-0.28)
Insulin Infusion Pumps: World Market Analysis 2015-2019
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6qfb4/insulin_infusion) has announced the addition of the "Insulin Infusion Pumps: World Market Analysis" report to their offering. Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient's circulatory system. Insulin infusion pumps are considered specialty medical infusion pumps, ambulatory electromechanical pumps typically used to deliver insulin to patients with diabetes. They provide precise insulin delivery and lifestyle flexibility for people with diabetes by delivering small amounts of insulin continuously (24/7) to ensure normal function of the body. Insulin Infusion Pumps: World Market Analysis analyzes the current and potential world market for insulin infusion pumps, with market forecasts to 2019. The report includes discussion of: - Key Insulin Pump Products, Manufacturers, and Recent Developments - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Safety Issues - Advances in the Market The profiled companies include: - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INSULIN INFUSION PUMPS - Brief History of the Infusion Pump Industry - Diabetes Statistics, United States and Europe - Insulin Infusion Pumps - Continuous Glucose Monitoring Systems - Key Insulin Pump Products, Manufacturers, and Recent Developments - Animas Corporation - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care, Inc. - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Manufacturer Profiles - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development Co., Ltd - Tandem Diabetes Care, Inc. - Safety Issues - Advances in the Market For more information visit http://www.researchandmarkets.com/research/r6...n_infusion
JNJ: 101.08 (+0.62), PODD: 30.72 (+0.11), MDT: 77.61 (-0.89)
3 Stocks Driving The Health Care Sector Higher
at The Street - Mon Apr 20, 12:24PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
MDT: 77.61 (-0.89), UNH: 118.69 (+0.43), AMGN: 167.91 (-1.26)
IBM Employs Watson Capabilities Into Healthcare Analytics
Lior Ronen - at Seeking Alpha - Mon Apr 20, 11:25AM CDT
JNJ: 101.08 (+0.62), MCK: 229.20 (+0.09), MDT: 77.61 (-0.89), IBM: 169.78 (-0.46), AAPL: 130.28 (+0.61), CERN: 73.32 (+0.27)
Study of Upper Airway Stimulation (UAS) Therapy for Sleep Apnea Named a Top Ten Outstanding Research Paper
PR Newswire - Mon Apr 20, 11:00AM CDT
Inspire Medical Systems, Inc., announced today that a scientific paper on its Inspire Upper Airway Stimulation (UAS) therapy for obstructive sleep apnea (OSA), has been recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. The awards were announced at the Forum's Annual Meeting in Washington, D.C. The 10 winning papers were chosen based on their degree of innovation from a pool of more than 50 nominations from 30 research and academic health centers nationwide.
MDT: 77.61 (-0.89)
MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
M2 - Mon Apr 20, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgkmfx/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks" " subscription to their offering. Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries of Clinical Trials and Product Technologies. All Clinical Trial Summaries are indexed by Company, Principal Investigator (PI) and PI Study Site. All Product Technology Summaries are indexed by Company. The Summaries are updated throughout the month published in final form each month with Summary Update Emails sent to you and RSS Breaking News fed to you. For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI) Therapeutics - MarketTracks: As of January 2015 the Number of Clinical Trials/Registries included = 45; the Number of Product Technologies included = 25; the Number of Companies included = 22. This Subject Area is growing as its authors discover newly announced trials and emerging product technologies. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. Companies Companies Mentioned - Abbott Vascular Devices - AtheroMed, Inc. - Bard Peripheral Vascular, Inc. / C. R. Bard - BIOTRONIK - Boston Scientific Corporation, Inc. - Cardiovascular Systems, Inc. - Cook, Inc. - Covidien (eV3) - CryoVascular Systems, Inc. (Boston Scientific Corporation) - Edwards Lifesciences - EKOS Corporation - Guidant Corporation (Abbott Vascular Devices/Boston Scientific Corporation) - Intact Vascular, Inc. - Invatec (Medtronic) - Lutonix, Inc. - Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.)) - Medtronic Vascular - Spectranetics Corporation - TriReme Medical - Terumo Medical Corporation - Vascular Solutions, Inc. For more information visit http://www.researchandmarkets.com/research/fg...ntellibase
BSX: 18.34 (-0.08), SPNC: 26.52 (-8.18), MDT: 77.61 (-0.89), CSII: 37.22 (-2.00), EW: 138.33 (-3.59), VASC: 35.31 (+0.45)
North American Orthobiologics (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015-2019
M2 - Fri Apr 24, 9:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rkbq8c/north_american) has announced the addition of the "North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019" report to their offering. The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market. The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market. In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market. The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.). For more information visit http://www.researchandmarkets.com/research/rk...h_american
MDT: 77.61 (-0.89), GMED: 24.79 (+0.15), EXAC: 24.40 (+0.15), SYK: 96.90 (-0.28)
Pfizer's Once And Future Deals
Chris DeMuth Jr. - at Seeking Alpha - Thu Apr 23, 2:39PM CDT
SHAK: 68.53 (+5.80), GS: 197.99 (-1.32), MDT: 77.61 (-0.89), JPM: 62.60 (-0.20), SHPG: 255.11 (-0.26), COV: 106.71 (-1.36), PFE: 35.27 (-0.09), AZN: 71.79 (-1.34), BAC: 15.64 (-0.05), ABBV: 66.07 (+1.82), HSP: 87.61 (-0.05), MS: 37.36 (-0.02)
Global Weight Loss and Weight Management Market 2015-2019
M2 - Thu Apr 23, 8:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dhhrwt/weight_loss_and) has announced the addition of the "Weight Loss and Weight Management Market by Equipment, Surgical Equipment , Diet , Weight Loss Services - Forecast to 2019" report to their offering. The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9% from 2014 to 2019 Factors such as rising obesity rates, increasing risks of lifestyle diseases, increasing number of bariatric surgeries, increase in disposable incomes, and technological advancements are driving the growth of the weight loss and weight management market. Furthermore, strong government support and funding is another major factor promoting growth of this market. For instance, the U.K. government started theChange4Life initiative in 2009, a multipronged approach that encourages behavioral changes in people and includes marketing strategies such as advertising campaigns, websites, resources, and partnership opportunities to encourage people to eat well and live longer. Moreover, the U.K. government announced the launch of Call to Action on Obesity program. This program aims to set a weight reduction trend among children and adults by 2020. The program has also issued a calorie reduction challenge to the food and beverage industry to reduce daily calorie intake. Such support is likely to provide impetus for growth of this market. The relatively untapped Asian region provides an array of growth opportunities for the weight loss and weight management market. Large population base, rapid urbanization, increasing disposable incomes, rising prevalence of obesity, and growing awareness and health consciousness among citizens are the factors responsible for the growth of this market. To leverage these market opportunities and to reduce the manufacturing and distribution costs, various market players are building manufacturing facilities and strengthening their sales force in these developing economies. However, high cost of low-calorie diets and deceptive marketing strategies adopted by industry players are hindering the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.4 Weight Loss Management Market, By Diet 5 Market Overview 6 Industry Insights 7 Weight Loss & Weight Management Market, By Diet 8 Weight Loss & Weight Management Market, By Equipment 9 Weight Loss & Weight Management Market, By Service 10 Weight Loss & Weight Management Market, By Region 11 Competitive Landscape 12 Company Profiles - Amer Sports - Apollo Endosurgery, Inc. - Atkins Nutritionals, Inc. - Brunswick Corporation - Covidien PLC (Wholly-Owned Subsidiary of Medtronic PLC) - Cybex International, Inc. (A Wholly Owned Subsidiary of Um Holdings) - Ediets.Com, Inc. (A Wholly Owned Subsidiary of as Seen on TV, Inc.) - Ethicon (Subsidiary of Johnson & Johnson) - Herbalife Ltd. - Jenny Craig, Inc. (Subsidiary of North Castle Partners) - Johnson Health Technology Co., Ltd. - Kellogg Company - Nutrisystem, Inc. - Technogym SPA - Weight Watchers International, Inc. For more information visit http://www.researchandmarkets.com/research/dh...t_loss_and
JNJ: 101.08 (+0.62), HLF: 41.10 (-3.75), MDT: 77.61 (-0.89), BC: 55.27 (+0.78), WTW: 8.25 (+0.15), K: 63.73 (-0.12)
Global Electrophysiology Market Report 2014-2020
M2 - Thu Apr 23, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4wjt34/electrophysiology) has announced the addition of the "Electrophysiology Global Market Analysis - Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Electrophysiology. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Electrophysiology Market by Diagnostic Devices 5.1 X-ray Systems 5.2 Diagnostic Catheters 5.3 EMG 5.4 ECG 5.5 EEG 6 Electrophysiology Market by Therapeutic Devices 6.1 Cardiac Pacemakers 6.2 CRT 6.3 ICDs 6.4 Ablation Catheters 7 Geographical Segmentation 8 Vendor Landscaping 9 Company Profiles - Abbott Laboratories - Biotronik - Boston Scientific Corp. - C.R. Bard Inc. - Medtronic, Inc. - Siemens AG - St. Jude Medical Inc. For more information visit http://www.researchandmarkets.com/research/4w...physiology
BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), BCR: 175.38 (-0.87), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Look for Shares of Medtronic to Potentially Pullback after Yesterday's 1.21% Rise
Comtex SmarTrend(R) - Wed Apr 22, 4:22PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 77.61 (-0.89)
After Yesterday's Rally of 1.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 22, 4:21PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $77.06 to a high of $78.12. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.53 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 77.61 (-0.89)
Inspire Therapy Approved for Sleep Apnea Patients at Military and VA Hospitals
PR Newswire - Wed Apr 22, 10:46AM CDT
Inspire Medical Systems, Inc., announced today that Inspire® Upper Airway Stimulation (UAS) therapy has been approved for inclusion in the Government Services Administration (GSA) Federal Supply Schedule (FSS). The agreement enables access to Inspire therapy to patients cared for at Veteran Administration hospitals, military treatment facilities, and Indian Health Services hospitals. Inspire therapy is an FDA approved implantable device for the treatment of Obstructive Sleep Apnea (OSA), a common condition affecting 18 million Americans.
MDT: 77.61 (-0.89)
North American Nerve Repair & Regeneration Market by Type, by Procedure - Forecast to 2019
M2 - Wed Apr 22, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hs9468/north_american) has announced the addition of the "North American Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) -Forecast to 2019" report to their offering. The North American nerve repair and regeneration market was valued at $1,671.4 million in 2014. It is projected to reach $2,873.0 million by 2019, at a CAGR of 11.4% during the forecast period. The market, by type, is segmented into nerve repair by neurostimulation (held largest share in 2014) and nerve repair by biomaterials. In North America, the U.S. is a key region the for nerve repair and regeneration market. Nerve repair and regeneration deals with healing damaged nerves and restoring any functioning of body parts lost due to nerve damage. This is one of the more challenging of neurological procedures. The growth of nerve repair and regeneration market has been rapid in all countries, mainly due to the constantly rising surgeries pertaining to nerves and the high incidence of chronic neurological disorders like epilepsy, Parkinson's, and Alzheimer's diseases. The increase in neurological surgeries drives the need for products such as nerve conduits, wraps, protectors, and connectors; thus, it is a driver of market growth. The North American nerve repair and regeneration market constitutes 32.8% of the global nerve repair and regeneration. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Product 6 Nerve Repair and Regeneration Market, By Country 7 Nerve Repair and Regeneration Market: Competitive Landscape 8 Nerve Repair and Regeneration Market: Company Profiles - Axogen, Inc. - Integra Lifesciences Corporation - Medtronic, Plc. - Polyganics - St. Jude Medical - Stryker For more information visit http://www.researchandmarkets.com/research/hs...h_american
MDT: 77.61 (-0.89), STJ: 73.47 (-0.54)
Medtronic DBS systems cleared for full-body MRI in Europe
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 9:38AM CDT
MDT: 77.61 (-0.89)
Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) - Forecast to 2019
M2 - Wed Apr 22, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2c5p7/asian_internal) has announced the addition of the "Asian Internal Neurostimulation/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019" report to their offering. The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019 Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market. In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Asia-Pacific Internal Neuromodulation/Neurostimulation Market: Macro Indicators, By Geography, 2014 ($ Bn) 4 Executive Summary 5 Market Overview 6 Internal Neurostimulation/Neuromodulation Market, By Modality 7 Internal Neurostimulation/Neuromodulation Market, By Application 8 Internal Neurostimulation/Neuromodulation Market, By Geography 9 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape 10 Internal Neurostimulation/ Neuromodulation Market, By Company - Boston Scientific Corporation (U.S.) - Cerbomed Gmbh (Germany) - Cyberonics, Inc. (U.S.) - Depuy Synthes Companies (U.S.) - Enteromedics, Inc. (U.S.) - Medtronic, Inc. (U.S.) - St. Jude Medical (U.S.) - Synapse Biomedical, Inc. (U.S.) - Uroplasty, Inc. (U.S.) For more information visit http://www.researchandmarkets.com/research/c2...n_internal
BSX: 18.34 (-0.08), MDT: 77.61 (-0.89), STJ: 73.47 (-0.54), UPI: 1.22 (-0.03), CYBX: 62.89 (-0.30)
Health Care Equipment and Supplies Equities Technical Data - Medtronic, ResMed, Unilife, Edwards Lifesciences, and InspireMD
PR Newswire - Wed Apr 22, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
UNIS: 3.56 (-0.18), MDT: 77.61 (-0.89), RMD: 65.70 (-7.68), EW: 138.33 (-3.59), NSPR: 0.26 (-0.02)
3 Things to Know About Apple and IBM's Most Recent Cloud Computing Innovation
Andrew Tonner, The Motley Fool - Motley Fool - Tue Apr 21, 1:03PM CDT
IBM's and Apple's CEOs. Image source: IBM Beyond plenty of publicity, just what have Apple and IBM gained from the much-ballyhooed partnership they announced last July? Well, since then, Apple and IBM have introduced 23 enterprise-focused...
JNJ: 101.08 (+0.62), MDT: 77.61 (-0.89), IBM: 169.78 (-0.46), AAPL: 130.28 (+0.61)
Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System
M2 - Tue Apr 21, 11:26AM CDT
Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery (LSA).
MDT: 77.61 (-0.89)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 77.61 (-0.89), SYK: 96.90 (-0.28)
Insulin Infusion Pumps: World Market Analysis 2015-2019
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6qfb4/insulin_infusion) has announced the addition of the "Insulin Infusion Pumps: World Market Analysis" report to their offering. Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient's circulatory system. Insulin infusion pumps are considered specialty medical infusion pumps, ambulatory electromechanical pumps typically used to deliver insulin to patients with diabetes. They provide precise insulin delivery and lifestyle flexibility for people with diabetes by delivering small amounts of insulin continuously (24/7) to ensure normal function of the body. Insulin Infusion Pumps: World Market Analysis analyzes the current and potential world market for insulin infusion pumps, with market forecasts to 2019. The report includes discussion of: - Key Insulin Pump Products, Manufacturers, and Recent Developments - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Safety Issues - Advances in the Market The profiled companies include: - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INSULIN INFUSION PUMPS - Brief History of the Infusion Pump Industry - Diabetes Statistics, United States and Europe - Insulin Infusion Pumps - Continuous Glucose Monitoring Systems - Key Insulin Pump Products, Manufacturers, and Recent Developments - Animas Corporation - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development - Tandem Diabetes Care, Inc. - Market Summary - Competitive Summary - Insulin Infusion Pumps in the Specialty Infusion Pumps Market - Geographical Market Analysis - Manufacturer Profiles - Animas Corporation/Johnson & Johnson - Asante Solutions - Cellnovo - Insulet Corporation - Medtronic - Roche Diabetes Care - Smiths Medical - SOOIL Development Co., Ltd - Tandem Diabetes Care, Inc. - Safety Issues - Advances in the Market For more information visit http://www.researchandmarkets.com/research/r6...n_infusion
JNJ: 101.08 (+0.62), PODD: 30.72 (+0.11), MDT: 77.61 (-0.89)
3 Stocks Driving The Health Care Sector Higher
at The Street - Mon Apr 20, 12:24PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
MDT: 77.61 (-0.89), UNH: 118.69 (+0.43), AMGN: 167.91 (-1.26)
IBM Employs Watson Capabilities Into Healthcare Analytics
Lior Ronen - at Seeking Alpha - Mon Apr 20, 11:25AM CDT
JNJ: 101.08 (+0.62), MCK: 229.20 (+0.09), MDT: 77.61 (-0.89), IBM: 169.78 (-0.46), AAPL: 130.28 (+0.61), CERN: 73.32 (+0.27)
Study of Upper Airway Stimulation (UAS) Therapy for Sleep Apnea Named a Top Ten Outstanding Research Paper
PR Newswire - Mon Apr 20, 11:00AM CDT
Inspire Medical Systems, Inc., announced today that a scientific paper on its Inspire Upper Airway Stimulation (UAS) therapy for obstructive sleep apnea (OSA), has been recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. The awards were announced at the Forum's Annual Meeting in Washington, D.C. The 10 winning papers were chosen based on their degree of innovation from a pool of more than 50 nominations from 30 research and academic health centers nationwide.
MDT: 77.61 (-0.89)
MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
M2 - Mon Apr 20, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgkmfx/medintellibase) has announced the addition of the "MedIntelliBase? Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks"
" subscription to their offering. Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable services help biotech, medical device and pharmaceutical companies gain and sustain their competitive advantage. MedIntelliBase gives you customized cloud and mobile intelligence services to satisfy your highly specialized information collection and reporting needs. Highly customized, precisely targeted intelligence on areas of business, finance, regulations, clinical research and medical technology interest are pushed, streamed and accessed as you require. In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries of Clinical Trials and Product Technologies. All Clinical Trial Summaries are indexed by Company, Principal Investigator (PI) and PI Study Site. All Product Technology Summaries are indexed by Company. The Summaries are updated throughout the month published in final form each month with Summary Update Emails sent to you and RSS Breaking News fed to you. For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI) Therapeutics - MarketTracks: As of January 2015 the Number of Clinical Trials/Registries included = 45; the Number of Product Technologies included = 25; the Number of Companies included = 22. This Subject Area is growing as its authors discover newly announced trials and emerging product technologies. Key Topics Covered: 1. Arteries 2. Therapeutic Approach 3. Clinical Focus 4. Companies Companies Mentioned - Abbott Vascular Devices - AtheroMed, Inc. - Bard Peripheral Vascular, Inc. / C. R. Bard - BIOTRONIK - Boston Scientific Corporation, Inc. - Cardiovascular Systems, Inc. - Cook, Inc. - Covidien (eV3) - CryoVascular Systems, Inc. (Boston Scientific Corporation) - Edwards Lifesciences - EKOS Corporation - Guidant Corporation (Abbott Vascular Devices/Boston Scientific Corporation) - Intact Vascular, Inc. - Invatec (Medtronic) - Lutonix, Inc. - Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.)) - Medtronic Vascular - Spectranetics Corporation - TriReme Medical - Terumo Medical Corporation - Vascular Solutions, Inc. For more information visit http://www.researchandmarkets.com/research/fg...ntellibase BSX: 18.34 (-0.08), SPNC: 26.52 (-8.18), MDT: 77.61 (-0.89), CSII: 37.22 (-2.00), EW: 138.33 (-3.59), VASC: 35.31 (+0.45)
